ARKF vs IBB
ARK Fintech Innovation ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.75% for ARKF.
- • IBB pays a higher dividend yield (0.22%).
Side-by-side metrics
| Metric | ARKF | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.11% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $724M | $9.09B |
YTD return | -13.99% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.16 | 0.69 |
P/E ratio | 39.46 | 24.79 |
Last price | $41.40 | $196.62 |
Inception | — | — |
Issuer | ARK | iShares |
ARKF top holdings
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 9.46% |
| HOOD | Robinhood Markets Inc Class A | 6.26% |
| XYZ | Block Inc Class A | 6.07% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 5.23% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 4.88% |
| TOST | Toast Inc Class A | 4.44% |
| AMD | Advanced Micro Devices Inc | 3.95% |
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 3.95% |
| AMZN | Amazon.com Inc | 3.82% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About ARKF
ARKF (ARK Fintech Innovation ETF) is Fintech companies disrupting financial services. Managed by ARK, the fund carries $724M in assets under management, an expense ratio of 0.75%, a dividend yield of 0.11%. Its largest holding is Shopify Inc Registered Shs -A- Subord Vtg (SHOP), which represents 9.5% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 16.0%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.